CSBR

Champions Oncology, Inc. is a technology-enabled oncology solutions company providing drug development services to pharmaceutical and biotechnology companies. Headquartered in Hackensack, New Jersey, the company operates the TumorGraft platform, which uses patient-derived tumor models to predict clinical outcomes and optimize cancer drug development. Champions Oncology offers preclinical services including efficacy studies, biomarker discovery, and personalized medicine approaches. The company's platform helps accelerate oncology drug development by providing more predictive preclinical data.